Soleno Therapeutics Inc financial data

Symbol
SLNO on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
203 Redwood Shores Parkway, Suite 500, Redwood City, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Capnia, Inc. (to 5/11/2017)
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.02K % +384%
Debt-to-equity 18.6 % -89%
Return On Equity -43.3 % +84.6%
Return On Assets -36.5 % +65.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 38.9M shares +289%
Common Stock, Shares, Outstanding 38.4M shares +320%
Entity Public Float 33.1M USD +324%
Common Stock, Value, Issued 38K USD +280%
Weighted Average Number of Shares Outstanding, Basic 38.6M shares +271%
Weighted Average Number of Shares Outstanding, Diluted 38.6M shares +271%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 41.7M USD +131%
General and Administrative Expense 26.8M USD +149%
Operating Income (Loss) -72.6M USD -151%
Nonoperating Income (Expense) 7.23M USD +1381%
Net Income (Loss) Attributable to Parent -65.4M USD -130%
Earnings Per Share, Basic -1.83 USD/shares +33.9%
Earnings Per Share, Diluted -1.83 USD/shares +33.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 57M USD +194%
Marketable Securities, Current 209M USD
Assets, Current 268M USD +1205%
Property, Plant and Equipment, Net 19K USD 0%
Operating Lease, Right-of-Use Asset 268K USD -50.5%
Intangible Assets, Net (Excluding Goodwill) 7.78M USD -20%
Other Assets, Noncurrent 83K USD -49.7%
Assets 304M USD +883%
Accounts Payable, Current 3.72M USD +7.96%
Employee-related Liabilities, Current 2.15M USD +84.5%
Liabilities, Current 9.15M USD +4%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 23.4M USD +26.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -153K USD
Retained Earnings (Accumulated Deficit) -320M USD -25.7%
Stockholders' Equity Attributable to Parent 281M USD +2159%
Liabilities and Equity 304M USD +883%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.5M USD -86.2%
Net Cash Provided by (Used in) Financing Activities 938K USD
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 38.4M shares +320%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -127M USD -1785%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 57M USD +194%
Deferred Tax Assets, Valuation Allowance 66M USD +15.7%
Deferred Tax Assets, Gross 67.9M USD +13.2%
Operating Lease, Liability 296K USD
Payments to Acquire Property, Plant, and Equipment 11K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -21.9M USD -158%
Lessee, Operating Lease, Liability, to be Paid 309K USD
Property, Plant and Equipment, Gross 101K USD 0%
Operating Lease, Liability, Current 296K USD +39.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year One 175K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 13K USD +27560%
Lessee, Operating Lease, Liability, to be Paid, Year Three 0 USD
Deferred Tax Assets, Operating Loss Carryforwards 51.5M USD +5.01%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 2.94M USD +51.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD
Operating Lease, Payments 64K USD -46.2%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 66M USD +15.7%
Share-based Payment Arrangement, Expense 17.7M USD +462%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%